The ProSPoNS Trial: Statistical Analysis Protocol for Evaluating Efficacy of Probiotic Supplementation for Prevention of Neonatal Sepsis in 0–2-month-old Low Birth Weight Infants in India

Abstract Introduction: A Phase III multicentre randomised, double-blind, placebo-controlled trial evaluating the role of probiotics in the prevention of neonatal sepsis in 0–2-month-old Indian infants was conducted at six study sites in India, funded by UKRI-MRC and coordinated by ICMR. Methods and Analysis: The primary objective is to reduce the incidence of sepsis by 30%. This statistical analysis plan (SAP) identifies the procedures to be applied to the primary and secondary analyses for the ProSPoNS trial once the trial data are completed. The SAP was finalised during trial implementation, and all analyses were prospectively defined. This article briefly describes the study design and statistical methods used to analyse the primary and secondary outcomes. The SAP also outlines the planned sensitivity and subgroup analyses that will be performed to explore the robustness and generalisability of the results. The document describes methods for handling missing data, controlling for confounding variables and using statistical tests to compare the treatment groups. It also describes sensitivity or subgroup analyses that will be performed.

Authors

Institutions

Publication Details

Journal
Preventive Medicine Research & Reviews
Published
2025-10-28
DOI
https://doi.org/10.4103/pmrr.pmrr_121_25
Primary Topic
Neonatal and Maternal Infections
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The ProSPoNS Trial: Statistical Analysis Protocol for Evaluating Efficacy of Probiotic Supplementation for Prevention of Neonatal Sepsis in 0–2-month-old Low Birth Weight Infants in India

Rishikesh Sudhakar, Kamaleshwar S Mahajan, Subodh S. Gupta, Girish Dayma et al.
Preventive Medicine Research & Reviews
Neonatal and Maternal Infections
article

The ProSPoNS Trial: Statistical Analysis Protocol for Evaluating Efficacy of Probiotic Supplementation for Prevention of Neonatal Sepsis in 0–2-month-old Low Birth Weight Infants in India

Rishikesh Sudhakar, Kamaleshwar S Mahajan, Subodh S. Gupta, Girish Dayma, Rashmita B. Nayak, Anand Kawade, Ashish Bavdekar, Rajni Gaind, Narendra K. Arora, Sunil Sazawal, Sushma Nangia, Arti Kapil, Dilip Raja, B. Adhisivam, Tharikka Fathima, Anju Sinha, Abhishek Raut, S. N. Parida, Ramesh Poluru, Mohd. Azam, Prabhabati Devi, Ravindra Mohan Pandey
article en

Abstract

Abstract Introduction: A Phase III multicentre randomised, double-blind, placebo-controlled trial evaluating the role of probiotics in the prevention of neonatal sepsis in 0–2-month-old Indian infants was conducted at six study sites in India, funded by UKRI-MRC and coordinated by ICMR. Methods and Analysis: The primary objective is to reduce the incidence of sepsis by 30%. This statistical analysis plan (SAP) identifies the procedures to be applied to the primary and secondary analyses for the ProSPoNS trial once the trial data are completed. The SAP was finalised during trial implementation, and all analyses were prospectively defined. This article briefly describes the study design and statistical methods used to analyse the primary and secondary outcomes. The SAP also outlines the planned sensitivity and subgroup analyses that will be performed to explore the robustness and generalisability of the results. The document describes methods for handling missing data, controlling for confounding variables and using statistical tests to compare the treatment groups. It also describes sensitivity or subgroup analyses that will be performed.

Preventive Medicine Research & ReviewsVol. 3(1)
Lady Hardinge Medical College (IN), Vardhman Mahavir Medical College & Safdarjung Hospital (IN), Indian Council of Medical Research (IN), Asian Institute of Public Health (IN), INCLEN Trust International (IN), Jawaharlal Institute of Post Graduate Medical Education and Research (IN), All India Institute of Medical Sciences (IN), Mahatma Gandhi Institute of Medical Sciences (IN)
Openalex Percentile: Top 58%
Neonatal and Maternal Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.